Apocynin reduces reactive oxygen species generation in airways of asthmatics

J. Stefanska, A. Sarniak, A. Wlodarczyk, Z. Doniec, D. Nowak, R. Pawliczak (Rabka, Poland)

Source: Annual Congress 2010 - New treatments for asthma and COPD
Session: New treatments for asthma and COPD
Session type: Thematic Poster Session
Number: 1159
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Introduction Asthma is an inflammatory disorder of airways with a spectrum of symptoms. Inflammation is thought to trigger symptoms of asthma directly and indirectly, implying that it is the primary cause of airway dysfunction in asthma. Reactive oxygen species (ROS) play an important role in inflammation in asthma. NADPH oxidase is an enzyme, responsible for ROS generation; the agent that selectively inhibits its activation is apocynin.
Aim of the study Pondering the anti-inflammatory feature of apocynin, we investigated the effect of nebulized apocynin in 10 nonsmoking asthmatics, in placebo-controlled, cross-over design study.
Methods Effects of apocynin (3 mg) have been evaluated 30, 60 and 120 minutes after nebulization by collecting exhaled breath condensate (EBC), in which we investigated H2O2, NO2¯ and NO3¯ concentrations. We also estimated safety parameters and NO2¯ concentration in serum.
Results Apocynin decreased H2O2 concentration in EBC 60 min after inhalation (0.26 μM vs. 0.47 μM, p>0.05) and 120 min after inhalation (0.21 μM vs. 0.42 μM, p<0.05), comparing to placebo. Apocynin also reduced NO2¯ concentration, 30 and 60 min after nebulization comparing to placebo (2.75 μM vs. 4.95 μM and 2.53 μM vs. 4.00 μM respectively, p<0.05). Moreover, apocynin decreased NO3¯ concentration at each time-point (3.19 μM vs. 8.61 μM after 30 min, 5.44 μM vs. 8.63 μM after 60 min and 4.02 μM vs. 9.14 μM after 120 min respectively, p<0.05). No apocynin influence on NO2¯ concentration in serum and safety parameters has been observed.
Conclusion Inhaled apocynin is effective and safe anti-inflammatory agent, which may be a promising compound to alleviate inflammatory process in respiratory diseases like asthma.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Stefanska, A. Sarniak, A. Wlodarczyk, Z. Doniec, D. Nowak, R. Pawliczak (Rabka, Poland). Apocynin reduces reactive oxygen species generation in airways of asthmatics. Eur Respir J 2010; 36: Suppl. 54, 1159

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Altered reactive oxygen species generation in neutrophils of children with pollinosis
Source: Eur Respir J 2005; 26: Suppl. 49, 589s
Year: 2005

Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Source: Eur Respir J 2004; 23: 496
Year: 2004


The influence of hydrogen peroxide on reactive oxygen species generation in monocytes of healthy children and with pollinosis
Source: Eur Respir J 2006; 28: Suppl. 50, 228s
Year: 2006

The role of reactive oxygen species in pulmonary inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 531s
Year: 2003

Altered mitochondrial reactive oxygen species (ROS) production in airway smooth muscle cells of severe asthma.
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019

Exhaled H2O2 correlates with the release of reactive oxygen species by blood phagocytes in healthy subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002

Reactive oxygen species generation and exhaled nitric oxide in atopic mild bronchial asthma in exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002

Active oxigen species generation by leukocytes in infants with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Reactive oxygen species concentrations are decreased by nebulized apocynin in exhaled breath condensate of healthy subjects
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Analysis of reactive oxygen species in sputum neutrophils during acute exacerbation of COPD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012

Ovalbumin challenge causes epithelial damage in murine airways by a substance P mediated generation of reactive oxygen species
Source: Eur Respir J 2002; 20: Suppl. 38, 94s
Year: 2002

Increased production of reactive oxygen species of systemic PMN from COPD patients in comparison to healthy controls
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010


Hydrogen gas alters the production of reactive oxygen species in alveolar epithelial cells in vitro
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012

Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Source: Eur Respir J 2003; 22: 457-461
Year: 2003



Hypoxia and reoxygenation modulate lung epithelial cell glutathione content, oxygen consumption and reactive oxygen species (ROS) production
Source: Eur Respir J 2001; 18: Suppl. 33, 182s
Year: 2001

Inhibition of reactive nitrogen species production in COPD airways: comparison between steroid and theophylline
Source: Eur Respir J 2005; 26: Suppl. 49, 293s
Year: 2005

Influence of nutritional features on the generation of reactive oxygen species in the lungs
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


LSC 2011 Abstract: Effect of inhaled apocynin on reactive oxygen species concentrations in exhaled breath condensate of asthmatics
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011

Role of complex I and III in the production of reactive oxygen species by mitochondria of peripheral muscle in COPD subjects
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009

Reactive oxygen and nitrogen species (ROS & RNS) are associated with respiratory muscle dysfunction in severe COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 120s
Year: 2004